CD8A and neoplasm: Increasing evidence suggests that CD3+, CD8+, and CD45RO+ cells play key roles in anti-tumor immune responses; furthermore, the number, type, and location of the infiltrating immune cells in primary tumors are a prognostic for disease-free survival and overall survival [5].